The industry’s leading drug discovery conference, drawing 1,000+ scientists and researchers to Boston each fall. Seven concurrent tracks cover AI/ML in drug discovery, novel targets, next-generation biologics, ADCs, PROTACs, and emerging modalities — spanning from target identification through lead optimization and into the clinic.